2021
DOI: 10.1210/clinem/dgab401
|View full text |Cite
|
Sign up to set email alerts
|

Correlation Between Plasma Catecholamines, Weight, and Diabetes in Pheochromocytoma and Paraganglioma

Abstract: Context Pheochromocytomas and paragangliomas (PCC/PGL) are neuroendocrine tumors with discrete catecholamine profiles that cause incompletely understood metabolic and physiologic changes. Objective The objective was to evaluate relationships between plasma catecholamines, body weight, and hemoglobin A1C (HA1C). We hypothesized that individual catecholamines would correlate negatively with weight and glucose control. … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
8
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 18 publications
(14 citation statements)
references
References 32 publications
2
8
0
Order By: Relevance
“…In our study, hypertension and diabetes were less frequent in the negative catecholamine group than the positive catecholamine group, which was expected owing to the effect of catecholamines on blood pressure and glucose metabolism [ 27 , 28 , 29 ]. Catecholamines also affect body weight during hypermetabolic and proinflammatory states [ 30 ]. As a result of a comparison between patients with negative catecholamines and patients with catecholamine-positive PPGLs, Heavner et al [ 6 ] reported that BMI was higher in patients with negative catecholamines; however, Kawashima et al [ 15 ] did not find a difference in BMI between their negative- and positive-catecholamine groups, and the results in this study were consistent with Kawashima et al’s.…”
Section: Discussionmentioning
confidence: 99%
“…In our study, hypertension and diabetes were less frequent in the negative catecholamine group than the positive catecholamine group, which was expected owing to the effect of catecholamines on blood pressure and glucose metabolism [ 27 , 28 , 29 ]. Catecholamines also affect body weight during hypermetabolic and proinflammatory states [ 30 ]. As a result of a comparison between patients with negative catecholamines and patients with catecholamine-positive PPGLs, Heavner et al [ 6 ] reported that BMI was higher in patients with negative catecholamines; however, Kawashima et al [ 15 ] did not find a difference in BMI between their negative- and positive-catecholamine groups, and the results in this study were consistent with Kawashima et al’s.…”
Section: Discussionmentioning
confidence: 99%
“…Subsequently she gained weight at a steady rate and was back to her normal weight (approximately 60 kg, BMI: 23.4 kg/m 2 ) on day 214. The initial weight stabilization and weight gain could be attributed to the alpha-blockade treatment as the excess catecholamines are known to increase metabolism in patients, resulting in weight loss ( 12 , 13 ). After approximately 2 months of alpha-blockade the patient regained the ability to swallow more solid foods which likely contributed to her further weight gain.…”
Section: Discussionmentioning
confidence: 99%
“…Patients with catecholamine producing PPGLs have an increased risk of developing diabetes ( 13 ). This is mainly caused by high levels of circulating catecholamines leading to compromised insulin secretion from the pancreatic β-cells, decreased glucose uptake, and increased insulin resistance ( 15 ).…”
Section: Discussionmentioning
confidence: 99%
“…Weight loss is also a sign of pheochromocytoma and occurs because of a catecholamine-induced hypermetabolic state. In a study of 360 patients with pheochromocytomas and paragangliomas, Krumeich et al 10 showed that norepinephrine and normetanephrine levels were inversely associated with weight. In addition, Petrák et al demonstrated that chronic catecholamine overproduction leads to a hypermetabolic state characterized by increased resting energy expenditure.…”
Section: Discussionmentioning
confidence: 99%